This message contains My NCBI what's new results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).
Do not reply directly to this message.
Sender's message:
Sent on Tuesday, 2009 Sep 29Search kinetoplastids OR kinetoplastid OR Kinetoplastida OR "trypanosoma brucei" OR leishmania OR brucei OR leishmaniasis OR "African trypanosomiasis"
Click here to view complete results in PubMed. (Results may change over time.)
To unsubscribe from these e-mail updates click here.
PubMed Results |
- 1: Med Mal Infect. 2009 Sep 22. [Epub ahead of print]
-
[Liposomal amphotericin B as treatment for visceral leishmaniasis in Europe, 2009.]
[Article in French]Service de médecine interne, centre hospitalier universitaire de Nice et université de Nice Sophia-Antipolis, France.
Visceral leishmaniasis (VL) causes an estimated 500,000 new cases of disease and more than 50,000 deaths a year. For more than 60 years, pentavalent antimonies were considered the standard therapy for VL. The emergence of Leishmania strains resistant to antimonials led to the evaluation of other treatments including amphotericin B and its lipidic derivatives. Clinical trials with liposomal amphotericin B demonstrated that total doses of 10 to 20mg/kg, administered according to various regimens, had a 90-98% efficacy in non-immunocompromised patients. Compared to antimonials, liposomal amphotericin B provides favorable efficacy/tolerance and cost efficacy ratios. The WHO recently produced consensus recommendations for the use of liposomal amphotericin B in VL. In Europe, liposomal amphotericin B has progressively become the reference treatment of VL in clinical practice, and it is recommended as the first line therapy.
PMID: 19783391 [PubMed - as supplied by publisher]
-
Related articles
- ReviewTreatment of leishmaniasis in HIV-positive patients.
Ann Trop Med Parasitol. 2003 Oct; 97 Suppl 1:135-42.
[Ann Trop Med Parasitol. 2003]
- Liposomal amphotericin B for the treatment of visceral leishmaniasis.
Clin Infect Dis. 2006 Oct 1; 43(7):917-24. Epub 2006 Aug 28.
[Clin Infect Dis. 2006]
- ReviewLiposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
Drugs. 2009; 69(3):361-92.
[Drugs. 2009]
- ReviewLiposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.
Drugs. 1998 Apr; 55(4):585-612.
[Drugs. 1998]
- Review[Canine leishmaniasis: evolution of the chemotherapeutic protocols]
Parassitologia. 2004 Jun; 46(1-2):231-4.
[Parassitologia. 2004]
- » See reviews... | » See all...
- ReviewTreatment of leishmaniasis in HIV-positive patients.
- 2: Int J Antimicrob Agents. 2009 Sep 25. [Epub ahead of print]
-
Apoptosis-like death in Leishmania donovani promastigotes induced by diospyrin and its ethanolamine derivative.
Department of Microbiology, Bose Institute, Calcutta 700054, India.
Previous studies have demonstrated that diospyrin (1), a quinonoid plant product, can inhibit the growth of Leishmania donovani parasites. Here, several derivatives of 1 were evaluated by the MTT assay and it was observed that the ethanolamine analogue (10) exhibited maximum cytotoxicity [50% inhibitory concentration (IC(50))=2.9muM] against L. donovani promastigotes. Subsequently, the mode of cell death in promastigotes was investigated through externalisation of membrane-associated phosphatidylserine, mitochondrial membrane depolarisation, DNA laddering and in situ labelling of DNA fragmentation by terminal deoxyribonucleotidyl transferase-mediated dUTP nick-end labelling (TUNEL) methods. Whilst both 1 and 10 were found to induce apoptosis-like death in promastigotes, the effect of 10 was evidently stronger even at a lower concentration. Hence, the ethanolamine derivative (10) of diospyrin (1) may be a prospective 'lead' for the development of novel cytotoxic agents inducing apoptosis in L. donovani parasites.
PMID: 19783125 [PubMed - as supplied by publisher]
-
Related articles
- Aloe vera leaf exudate induces a caspase-independent cell death in Leishmania donovani promastigotes.
J Med Microbiol. 2007 May; 56(Pt 5):629-36.
[J Med Microbiol. 2007]
- Diospyrin, a bisnaphthoquinone: a novel inhibitor of type I DNA topoisomerase of Leishmania donovani.
Mol Pharmacol. 1998 Dec; 54(6):994-9.
[Mol Pharmacol. 1998]
- Artemisinin triggers induction of cell-cycle arrest and apoptosis in Leishmania donovani promastigotes.
J Med Microbiol. 2007 Sep; 56(Pt 9):1213-8.
[J Med Microbiol. 2007]
- Racemoside A, an anti-leishmanial, water-soluble, natural steroidal saponin, induces programmed cell death in Leishmania donovani.
J Med Microbiol. 2007 Sep; 56(Pt 9):1196-204.
[J Med Microbiol. 2007]
- ReviewApoptosis in Leishmania species & its relevance to disease pathogenesis.
Indian J Med Res. 2006 Mar; 123(3):233-44.
[Indian J Med Res. 2006]
- » See reviews... | » See all...
- Aloe vera leaf exudate induces a caspase-independent cell death in Leishmania donovani promastigotes.
- 3: Acta Trop. 2009 Sep 24. [Epub ahead of print]
-
Characterization of Leishmania (Leishmania) tropica axenic amastigotes.
Kuvin Centre for the Study of Tropical and Infectious Diseases, IMRIC, Hebrew University-Hadassah Medical School, P.O. Box 12272, Jerusalem 91120, Israel; Institute of Microbiology and Hygiene, Charite University Medicine, Berlin, Dorotheenstr. 96, 10117 Berlin, Germany.
Optimum conditions for generating Leishmania (Leishmania) tropica axenic amastigotes (AxA) in culture were determined, pH 5.5/36(o)C, and the parasites characterized by different techniques, including light microscopy, macrophage infection, stage-specific antigen expression and differential display. AxA were morphologically similar to amastigotes and 15.5-fold more infective than stationary phase promastigotes for mouse peritoneal macrophages. Western blotting with promastigote stage specific monoclonal antibodies to either lipophosphoglycan (T2) or a 60 kDa flagella antigen (F3) showed a dramatic decrease in antigen expression when AxA were compared to promastigotes. Similarly F3 gave strong immune fluorescent staining of the promastigote flagellum, but no fluorescence was detected when AxA were examined. Conversely, western blotting with the amastigote specific monoclonal antibody (T16) showed that this antigen is more highly expressed in AxA than promastigotes. Differential display - PCR was used to identify several parasite genes showing stage specific expression. One gene selectively expressed by AxA was partially sequenced and identified as Leishmania (L.) tropicaamastin. Amastigote specific expression of this gene was further confirmed by reverse transcriptase - PCR (RT-PCR) using AxA and infected macrophages. No amastin expression was observed with promastigotes. Expression of the cysteine protease B (cpb) and protein kinase A catalytic isoform 1 subunit (pkac1) in promastigotes and AxA was also examined by RT-PCR. Pkac1 was strongly expressed by promastigotes, while cpb expression was only seen with AxA or infected macrophages. L. (L.) tropica AxA will prove useful for further studies on parasite differentiation and gene regulation, as well as for drug screening.
PMID: 19782652 [PubMed - as supplied by publisher]
-
Related articles
- Characterization of developmentally-regulated activities in axenic amastigotes of Leishmania donovani.
Mol Biochem Parasitol. 1998 Sep 1; 95(1):9-20.
[Mol Biochem Parasitol. 1998]
- [Detection of P-4 and GP-46 expression in Leishmania amazonensis amastigotes and promastigotes by RT-PCR]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2006 Aug; 24(4):266-8.
[Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2006]
- Targeted gene deletion of Leishmania major genes encoding developmental stage-specific leishmanolysin (GP63).
Mol Microbiol. 1998 Feb; 27(3):519-30.
[Mol Microbiol. 1998]
- ReviewGlobal gene expression in Leishmania.
Int J Parasitol. 2007 Aug; 37(10):1077-86. Epub 2007 May 6.
[Int J Parasitol. 2007]
- ReviewDevelopmental life cycle of Leishmania--cultivation and characterization of cultured extracellular amastigotes.
J Eukaryot Microbiol. 1993 Mar-Apr; 40(2):213-23.
[J Eukaryot Microbiol. 1993]
- » See reviews... | » See all...
- Characterization of developmentally-regulated activities in axenic amastigotes of Leishmania donovani.
- 4: Diagn Microbiol Infect Dis. 2009 Sep 24. [Epub ahead of print]
-
Leishmania spp. identification by polymerase chain reaction-restriction fragment length polymorphism analysis and its applications in French Guiana.
Equipe EA 3593, Faculté de Médecine, Université des Antilles et de la Guyane, Cayenne, French Guiana.
Leishmania (Viannia) guyanensis was for many years the only species commonly identified in French Guiana, but precise species identifications were quite rare. We describe a new restriction fragment length polymorphism-polymerase chain reaction technique using a 615-bp fragment of the RNA polymerase II gene and 2 restriction enzymes, TspRI and HgaI. Seven reference strains (Leishmania (Leishmania) amazonensis, Leishmania (Viannia) lainsoni, Leishmania (Viannia) braziliensis, L. (V.) guyanensis, Leishmania (Viannia) naiffi, Leishmania (Leishmania) major, Leishmania (Leishmania) infantum) and 112 clinical samples from positive lesions were used for the development of the technique. The rates of positive species identification were 85.7% for punch skin biopsy specimens, 93.1% for positive Giemsa-stained smears, and 100% for positive culture supernatants. In the framework of cutaneous leishmaniasis species surveillance for the 2006 to 2008 period, parasite identification was carried out for 199 samples from different patients. The prevalence of the various Leishmania spp. was 84.4% for L. (V.) guyanensis, 8.0% for L. (V.) braziliensis, 5.0% for L. (L.) amazonensis, and 2.6% for L. (V.) lainsoni. L. (V.) braziliensis seems to be locally an emerging pathogen.
PMID: 19782495 [PubMed - as supplied by publisher]
-
Related articles
- Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.
J Infect Dis. 2007 Jun 15; 195(12):1846-51. Epub 2007 May 3.
[J Infect Dis. 2007]
- Species diversity causing human cutaneous leishmaniasis in Rio Branco, state of Acre, Brazil.
Trop Med Int Health. 2006 Sep; 11(9):1388-98.
[Trop Med Int Health. 2006]
- [PCR-RFLP and RAPD for typing neotropical Leishmania]
Biomedica. 2008 Dec; 28(4):597-606.
[Biomedica. 2008]
- ReviewClinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature.
Clin Infect Dis. 2007 Jun 15; 44(12):1602-10. Epub 2007 May 7.
[Clin Infect Dis. 2007]
- Review[Leishmania (Viannia) braziliensis Vianna, 1911 in French Guiana. Clinical, therapeutic and epidemiological considerations in the ninth human diagnosed case]
Bull Soc Pathol Exot. 1996; 89(5):341-4.
[Bull Soc Pathol Exot. 1996]
- » See reviews... | » See all...
- Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.
- 5: Semin Arthritis Rheum. 2009 Sep 24. [Epub ahead of print]
-
Leishmaniasis and Biologic Therapies for Rheumatologic Diseases.
Tropical and Parasitological Diseases Unit, Department of Human Pathology, University of Messina, Messina, Italy.
PMID: 19782386 [PubMed - as supplied by publisher]
-
Related articles
- ReviewEconomic issues with new rheumatologic therapeutics.
Curr Opin Rheumatol. 2007 May; 19(3):272-6.
[Curr Opin Rheumatol. 2007]
- ReviewVasculitis and biologic infusion therapies: implications for nursing.
J Infus Nurs. 2006 Sep-Oct; 29(5):272-82.
[J Infus Nurs. 2006]
- ReviewNew therapies: plasmapheresis, intravenous immunoglobulin, and monoclonal antibodies.
Crit Care Clin. 2002 Oct; 18(4):957-75.
[Crit Care Clin. 2002]
- Pharmacoeconomics and quality of life of current and emerging biologic therapies for inflammatory bowel disease.
Curr Treat Options Gastroenterol. 2007 Jun; 10(3):185-94.
[Curr Treat Options Gastroenterol. 2007]
- ReviewBiologic treatments for systemic rheumatic diseases.
Oral Dis. 2008 Apr; 14(3):206-16. Epub 2008 Feb 14.
[Oral Dis. 2008]
- » See reviews... | » See all...
- ReviewEconomic issues with new rheumatologic therapeutics.
- 6: Biochim Biophys Acta. 2009 Sep 23. [Epub ahead of print]
-
A new topology of ACBP from Moniliophthora perniciosa.
Departamento de Ciências Biológicas, Laboratório de Proteômica, Centro de Biotecnologia e Genética, Universidade Estadual de Santa Cruz, Ilhéus - BA, CEP 45662-900. Brazil.
Acyl-CoA binding protein (ACBP) is a housekeeping protein and is an essential protein in human cell lines and in Trypanosoma brucei. The ACBP of Moniliophthora perniciosa is composed of 104 amino acids and is possibly a non-classic isoform exclusively from Basidiomycetes. The M. perniciosa acbp gene was cloned, and the protein was expressed and purified. Acyl-CoA ester binding was analyzed by isoelectric focusing, native gel electrophoresis and isothermal titration calorimetry. Our results suggest an increasing affinity of ACBP for longer acyl-CoA esters, such as myristoyl-CoA to arachidoyl-CoA, and best fit modeling indicates two binding sites. ACBP undergoes a shift from a monomeric to a dimeric state, as shown by dynamic light scattering, fluorescence anisotropy and native gel electrophoresis in the absence and presence of the ligand. The protein's structure was determined at 1.6 A resolution and revealed a new topology for ACBP, containing five alpha-helices instead four. alpha-helices 1, 2, 3 and 4 adopted a bundled arrangement that is unique from the previously determined four-helix folds of ACBP, while alpha-helices 1, 2, 4 and 5 formed a classical four-helix bundle. A MES molecule was found in the CoA binding site, suggesting that the CoA site could be a target for small compound screening.
PMID: 19782157 [PubMed - as supplied by publisher]
-
Related articles
- High resolution crystal structures of unliganded and liganded human liver ACBP reveal a new mode of binding for the acyl-CoA ligand.
Proteins. 2007 Jan 1; 66(1):229-38.
[Proteins. 2007]
- Yeast acyl-CoA-binding protein: acyl-CoA-binding affinity and effect on intracellular acyl-CoA pool size.
Biochem J. 1994 Sep 1; 302 ( Pt 2):479-85.
[Biochem J. 1994]
- Structure and function of normal and transformed murine acyl-CoA binding proteins.
Arch Biochem Biophys. 1998 Feb 15; 350(2):201-13.
[Arch Biochem Biophys. 1998]
- ReviewThe function of acyl-CoA-binding protein (ACBP)/diazepam binding inhibitor (DBI).
Mol Cell Biochem. 1993 Jun 9-23; 123(1-2):129-38.
[Mol Cell Biochem. 1993]
- ReviewAcyl-CoA-binding protein (ACBP) and its relation to fatty acid-binding protein (FABP): an overview.
Mol Cell Biochem. 1990 Oct 15-Nov 8; 98(1-2):217-23.
[Mol Cell Biochem. 1990]
- » See reviews... | » See all...
- High resolution crystal structures of unliganded and liganded human liver ACBP reveal a new mode of binding for the acyl-CoA ligand.
- 7: Mol Biochem Parasitol. 2009 Sep 23. [Epub ahead of print]
-
Myristoyl-CoA:protein N-myristoyltransferase depletion in trypanosomes causes avirulence and endocytic defects.
Centre for Immunology and Infection, Department of Biology/Hull York Medical School, University of York, York YO10 5YW, UK.
The enzyme myristoyl-CoA:protein N-myristoyltransferase (NMT) catalyses the co-translational covalent attachment of the fatty acid myristate to the N-terminus of target proteins. NMT is known to be essential for viability in Trypanosoma brucei and Leishmania major. Here we describe phenotypic analysis of T. brucei bloodstream form cells following knockdown of NMT expression by tetracycline-inducible RNA interference. Cell death occurs from 72h post-induction, with approximately 50% of cells displaying a defect in endocytic uptake by this time. The majority of these induced cells do not have an enlarged flagellar pocket typical of a block in endocytosis but vesicle accumulation around the flagellar pocket indicates a defect in vesicular progression following endocytic fusion. Induced parasites have a wild-type or slightly enlarged Golgi apparatus, unlike the phenotype of cells with reduced expression of a major N-myristoylated protein, ARL1. Critically we show that following NMT knockdown, T.brucei bloodstream form cells are unable to establish an infection in a mouse model, therefore providing further validation of this enzyme as a target for drug development.
PMID: 19782106 [PubMed - as supplied by publisher]
-
Related articles
- Functional analysis of TbARL1, an N-myristoylated Golgi protein essential for viability in bloodstream trypanosomes.
J Cell Sci. 2005 Feb 15; 118(Pt 4):831-41. Epub 2005 Feb 1.
[J Cell Sci. 2005]
- Myristoyl-CoA:protein N-myristoyltransferase, an essential enzyme and potential drug target in kinetoplastid parasites.
J Biol Chem. 2003 Feb 28; 278(9):7206-14. Epub 2002 Dec 17.
[J Biol Chem. 2003]
- ARL1 has an essential role in Trypanosoma brucei.
Biochem Soc Trans. 2005 Aug; 33(Pt 4):643-5.
[Biochem Soc Trans. 2005]
- ReviewSelective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: protein N-myristoyltransferase: a new approach to antifungal therapy.
Biopolymers. 1997; 43(1):43-71.
[Biopolymers. 1997]
- ReviewThe structure of myristoyl-CoA:protein N-myristoyltransferase.
Biochim Biophys Acta. 1999 Nov 23; 1441(2-3):162-72.
[Biochim Biophys Acta. 1999]
- » See reviews... | » See all...
Patient Drug Information
- Tetracycline (Helidac Therapy® (as a combination product containing Tetracycline, Metronidazole, and Bismuth subsalicylate), Sumycin®, Sumycin® Syrup)
Tetracycline, is used to treat bacterial infections, including pneumonia and other respiratory tract infections; acne; infections of skin, genital and urinary systems; and the infection that causes stomach ulcers (Helico...
- Functional analysis of TbARL1, an N-myristoylated Golgi protein essential for viability in bloodstream trypanosomes.
- 8: J Mol Biol. 2009 Sep 22. [Epub ahead of print]
-
Crystal structures of Leishmania mexicana phosphoglycerate mutase suggest a one-metal mechanism and a new enzyme subclass.
Structural Biochemistry Group, Institute of Structural and Molecular Biology, University of Edinburgh, King's Buildings, Mayfield Road, Edinburgh EH9 3JR, Scotland.
The structures of Leishmania mexicana cofactor-independent phosphoglycerate mutase (Lm iPGAM) crystallised with the substrate 3-phosphoglycerate at high and low cobalt concentrations have been solved at 2.00 and 1.90 A resolution. Both structures are very similar and the active site contains both 3- and 2-phosphoglycerate at equal occupancies (50%). Lm iPGAM co-crystallised with the product 2-phosphoglycerate yields the same structure. Two Co(2+) ions are coordinated within the active site with different geometries and affinities. The cobalt at the M1 site has a distorted octahedral geometry and is present at 100% occupancy. The M2 site Co(2+) ion binds with distorted tetrahedral geometry, with only partial occupancy, and coordinates with Ser75, the residue involved in phospho transfer. When the M2 site is occupied, the side chain of Ser75 adopts a position which is unfavourable for catalysis, indicating that this site may not be occupied under physiological conditions and that catalysis may occur via a one metal mechanism. The geometry of the M2 site suggests that it is possible for Ser75 to be activated for phospho transfer by H-bonding to nearby residues rather than by metal coordination. The 16 active-site residues of Lm iPGAM are conserved in the Mn-dependent iPGAM from Bacillus stearothermophilus (33% overall sequence identity). However, Lm iPGAM has an inserted tyrosine (Tyr210) that causes the M2 site to diminish in size, consistent with its reduced metal affinity. Tyr210 is present in trypanosomatid and plant iPGAMs, but not in the enzymes from other organisms, indicating that there are two subclasses of iPGAMs.
PMID: 19781556 [PubMed - as supplied by publisher]
-
Related articles
- Structure and mechanism of action of a cofactor-dependent phosphoglycerate mutase homolog from Bacillus stearothermophilus with broad specificity phosphatase activity.
J Mol Biol. 2002 Feb 1; 315(5):1129-43.
[J Mol Biol. 2002]
- Mechanism of catalysis of the cofactor-independent phosphoglycerate mutase from Bacillus stearothermophilus. Crystal structure of the complex with 2-phosphoglycerate.
J Biol Chem. 2000 Jul 28; 275(30):23146-53.
[J Biol Chem. 2000]
- Characterization of the cofactor-independent phosphoglycerate mutase from Leishmania mexicana mexicana. Histidines that coordinate the two metal ions in the active site show different susceptibilities to irreversible chemical modification.
Eur J Biochem. 2004 May; 271(9):1798-810.
[Eur J Biochem. 2004]
- ReviewThe phosphoglycerate mutases.
Adv Enzymol Relat Areas Mol Biol. 1989; 62:227-313.
[Adv Enzymol Relat Areas Mol Biol. 1989]
- ReviewDifferential behavior of the sub-sites of cytochrome 450 active site in binding of substrates, and products (implications for coupling/uncoupling).
Biochim Biophys Acta. 2007 Mar; 1770(3):360-75. Epub 2006 Oct 5.
[Biochim Biophys Acta. 2007]
- » See reviews... | » See all...
- Structure and mechanism of action of a cofactor-dependent phosphoglycerate mutase homolog from Bacillus stearothermophilus with broad specificity phosphatase activity.
- 9: Malawi Med J. 2009 Mar;21(1):22-7.
-
The epidemiology of trypanosomiasis in Rumphi district, Malawi: a ten year retrospective study.
College of Medicine, Malawi. mmadanitsa2004@yahoo.com
BACKGROUND: Human African Trypanosomiasis (HAT) is caused by two species of the tsetse fly vectored protozoan hemoflagellates belonging to Trypanosma brucei, namely T.b gambiense which predominates in Western Africa and follows a chronic disease course and T.b rhodensiense which is more prevalent in Southern and Eastern Africa, Malawi included, and follows a more acute and aggressive disease course. Previous studies in the Democratic Republic of Congo, Angola, Uganda and Sudan have demonstrated that the prevalence rates of T.b rhodensiense infection have reached epidemic proportions. OBJECTIVES: To describe the epidemiology of Trypanosomiasis in Rumphi District over the past ten years. METHODOLOGY: A total of 163 records from January 2000 to December 2006 were retrospectively studied. RESULTS: There were more males than females (121 vs. 40) with the 20 - 29 years age bracket having the highest number of cases (26.3%, n = 160). Stage 2 HAT was the commonest stage at presentation (58.2%, n = 158) with the patients in the same being 3.5 times more likely to die than those with stage 1 HAT. Case fatality rates for late and early stage disease were 21.5% (n = 92) and 7.2% (n = 66) respectively with 84.6% having been cured (n = 162). Convulsions were associated with fatal disease outcome and the majority of cases (97.2%, n = 103) lived within 5 kilometres of the Vwaza game reserve boundary. CONCLUSION: More men have been infected than women, with a high involvement in the 20 - 29 age brackets. A dramatic increase with active case finding indicates a high under-detection of the disease with late stage HAT being predominant at presentation. Though it has been found that cases with late stage disease have an increased likelihood of dying compared to those in early stage HAT, the high proportion of successful treatment indicates that the disease still carries a high degree of favourable outcome with treatment. It has also been demonstrated in this study that more than 95% of trypanosomiasis cases live within 5 km of game reserve boundary. Disease interventions should be implemented in areas within 5 km of marshland game reserve boundary as priority areas.
PMID: 19780474 [PubMed - in process]
-
Related articles
- Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
Lancet. 2009 Jul 4; 374(9683):56-64. Epub 2009 Jun 24.
[Lancet. 2009]
- ReviewThe epidemiology and control of human African trypanosomiasis.
Adv Parasitol. 2001; 49:71-132.
[Adv Parasitol. 2001]
- Cardiac Alterations in Human African Trypanosomiasis (T.b. gambiense) with Respect to the Disease Stage and Antiparasitic Treatment.
PLoS Negl Trop Dis. 2009; 3(2):e383. Epub 2009 Feb 17.
[PLoS Negl Trop Dis. 2009]
- Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo.
Bull World Health Organ. 2006 Oct; 84(10):777-82.
[Bull World Health Organ. 2006]
- ReviewHuman African trypanosomiasis-neurological aspects.
J Neurol. 2006 Apr; 253(4):411-6. Epub 2006 Mar 20.
[J Neurol. 2006]
- » See reviews... | » See all...
- Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
- 10: Mil Med. 2009 Sep;174(9):904-20.
-
Use of vector diagnostics during military deployments: recent experience in Iraq and Afghanistan.
Department of Entomology, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
Vector-borne diseases such as malaria, dengue, and leishmaniasis are a threat to military forces deployed outside of the United States. The availability of specific information on the vector-borne disease threat (e.g., presence or absence of a specific disease agent, temporal and geographic distribution of competent vectors, and vector infection rates) allows for effective implementation of appropriate measures to protect our deployed military forces. Vector diagnostics can provide critical, real-time information crucial to establishing effective vector prevention/control programs. In this article we provide an overview of current vector diagnostic capabilities, evaluate the use of vector diagnostics in Operation Enduring Freedom and Operation Iraqi Freedom, and discuss the concept of operations under which vector diagnostics are employed.
PMID: 19780365 [PubMed - in process]
-
Related articles
- Impact of phlebotomine sand flies on U.S. Military operations at Tallil Air Base, Iraq: 1. background, military situation, and development of a "Leishmaniasis Control Program".
J Med Entomol. 2006 Jul; 43(4):647-62.
[J Med Entomol. 2006]
- Self-reported description of diarrhea among military populations in operations Iraqi Freedom and Enduring Freedom.
J Travel Med. 2006 Mar-Apr; 13(2):92-9.
[J Travel Med. 2006]
- Factors associated with the use of protective measures against vector-borne diseases among troops deployed to Iraq and Afghanistan.
Mil Med. 2008 Nov; 173(11):1060-7.
[Mil Med. 2008]
- ReviewCritical care medicine at Walter Reed Army Medical Center in support of the global war on terrorism.
Crit Care Med. 2008 Jul; 36(7 Suppl):S388-94.
[Crit Care Med. 2008]
- ReviewOld world leishmaniasis: an emerging infection among deployed US military and civilian workers.
Clin Infect Dis. 2004 Dec 1; 39(11):1674-80. Epub 2004 Nov 9.
[Clin Infect Dis. 2004]
- » See reviews... | » See all...
- Impact of phlebotomine sand flies on U.S. Military operations at Tallil Air Base, Iraq: 1. background, military situation, and development of a "Leishmaniasis Control Program".
No comments:
Post a Comment